
Sanya Sukduang
Advertisement
Articles by Sanya Sukduang

Advertisement
Latest Updated Articles
Amgen and Sandoz: Battle Over Neupogen Biosimilar “Shall” ContinuePublished: June 5th 2015 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Implications of the First Liquid IV Infliximab Biosimilar
2
GSK Bets $50M on LTZ’s Immune-Engager Platform for Next-Gen Cancer Treatment
3
Why 503B Compounding Pharmacies Choose Prefabricated POD® Cleanrooms
4
Risks, Resource Strain, and Trade-Offs in FDA’s CNPV Pilot Program
5
